BD, Euroclone to develop tests for ST infections
Becton, Dickinson and Company (BD) and Italian diagnostic products maker Euroclone Diagnostica have entered an agreement for the development and global distribution of molecular tests to detect emerging sexually transmitted pathogens. The molecular tests are expected to improve the potential for an accurate diagnosis and treatment in the presence or absence of symptoms. In addition to supporting clinical laboratories for antimicrobial stewardship, the assays will help institutions to comply with European guidelines for sexually transmitted infections (STI) screening. The new assays will run on the fully automated BD MAX System to detect infectious genital mycoplasmas such as Mycoplasma and Ureaplasma species that are difficult to diagnose using standard methods. Lack of proper diagnosis and treatment of such infections are reported to result in immediate and long-term health consequences, including infertility and heightened HIV susceptibility.